CY1115401T1 - Συνθεσεις για χορηγηση απο του στοματος δραστικων ενωσεων που απαιτουν συγκαλυψη της γευσης - Google Patents

Συνθεσεις για χορηγηση απο του στοματος δραστικων ενωσεων που απαιτουν συγκαλυψη της γευσης

Info

Publication number
CY1115401T1
CY1115401T1 CY20141100434T CY141100434T CY1115401T1 CY 1115401 T1 CY1115401 T1 CY 1115401T1 CY 20141100434 T CY20141100434 T CY 20141100434T CY 141100434 T CY141100434 T CY 141100434T CY 1115401 T1 CY1115401 T1 CY 1115401T1
Authority
CY
Cyprus
Prior art keywords
oral administration
taste
compositions
cover
active compounds
Prior art date
Application number
CY20141100434T
Other languages
English (en)
Inventor
Isabelle Chacornac
Patricia Probeck
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1115401T1 publication Critical patent/CY1115401T1/el

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Μία σύνθεση η οποία προορίζεται για χορήγηση από του στόματος δραστικών ουσιών με μη αποδεκτή γεύση, με τι χαρακτηριστικό ότι περιέχει από 15 έως 30% δραστικής ουσίας αναμεμειγμένης με 60 έως 80% ενός εστέρα της γλυκερίνης ή ενός λιπαρού οξέος, στα οποία έχει ενδεχομένως προστεθεί ένας κηρός και έχει προστεθεί ένας επιφανειοδραστικός παράγοντας και παρασκευάζονται με μία μέθοδο ψύξης με ψεκασμό με την οποία μπορεί να επιτευχθεί μία κοκκομετρία μικρότερη από 350 μm.
CY20141100434T 2002-12-23 2014-06-12 Συνθεσεις για χορηγηση απο του στοματος δραστικων ενωσεων που απαιτουν συγκαλυψη της γευσης CY1115401T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0216521A FR2848855B1 (fr) 2002-12-23 2002-12-23 Compositions pour administration orale de principes actifs necessitant un masquage du gout
EP03799644.4A EP1587500B1 (fr) 2002-12-23 2003-12-19 Compositions pour administration orale de principes actifs necessitant un masquage du gout

Publications (1)

Publication Number Publication Date
CY1115401T1 true CY1115401T1 (el) 2017-01-04

Family

ID=32406402

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100434T CY1115401T1 (el) 2002-12-23 2014-06-12 Συνθεσεις για χορηγηση απο του στοματος δραστικων ενωσεων που απαιτουν συγκαλυψη της γευσης

Country Status (14)

Country Link
EP (1) EP1587500B1 (el)
JP (1) JP4676763B2 (el)
AU (1) AU2003299360B2 (el)
BR (1) BR0317654A (el)
CA (1) CA2510373C (el)
CY (1) CY1115401T1 (el)
DK (1) DK1587500T3 (el)
ES (1) ES2470371T3 (el)
FR (1) FR2848855B1 (el)
IL (1) IL169343A (el)
MX (1) MXPA05005640A (el)
PT (1) PT1587500E (el)
SI (1) SI1587500T1 (el)
WO (1) WO2004058137A2 (el)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1034065C2 (nl) 2007-06-29 2008-12-30 Friesland Brands Bv Bereiding van deeltjes.
FR2959130A1 (fr) 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
FR2968992B1 (fr) 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
FR2968995B1 (fr) 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
FR3000400B1 (fr) 2012-12-27 2019-06-21 Virbac Suspension huileuse de metronidazole
EP3076947B1 (en) * 2013-12-04 2018-06-13 Hovione Scientia Limited Contrast media containing taste masking formulations
FR3027802B1 (fr) 2014-10-31 2018-03-02 Ethypharm Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
JP3155028B2 (ja) * 1991-06-10 2001-04-09 大川原化工機株式会社 噴霧乾燥造粒装置
JPH05309314A (ja) * 1992-05-07 1993-11-22 Sumitomo Pharmaceut Co Ltd コーティング方法
JPH08510989A (ja) * 1992-10-16 1996-11-19 グラクソ、グループ、リミテッド ラニチジン組成物
CN100379407C (zh) * 1997-12-19 2008-04-09 史密丝克莱恩比彻姆公司 生产咀嚼分散片的方法
JP2000103730A (ja) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd 服用感が改善された医薬組成物
US6209479B1 (en) * 1998-12-30 2001-04-03 Aeromatic-Fielder Ag Apparatus for coating tablets
KR100768034B1 (ko) * 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 의약 조성물

Also Published As

Publication number Publication date
IL169343A0 (en) 2007-07-04
CA2510373A1 (fr) 2004-07-15
SI1587500T1 (sl) 2014-07-31
DK1587500T3 (da) 2014-06-23
JP2006515592A (ja) 2006-06-01
PT1587500E (pt) 2014-06-24
FR2848855A1 (fr) 2004-06-25
JP4676763B2 (ja) 2011-04-27
EP1587500B1 (fr) 2014-03-12
MXPA05005640A (es) 2005-07-27
ES2470371T3 (es) 2014-06-23
FR2848855B1 (fr) 2005-02-11
WO2004058137A3 (fr) 2005-04-14
AU2003299360B2 (en) 2009-10-29
CA2510373C (fr) 2014-09-30
BR0317654A (pt) 2005-12-20
IL169343A (en) 2011-06-30
AU2003299360A1 (en) 2004-07-22
EP1587500A2 (fr) 2005-10-26
WO2004058137A2 (fr) 2004-07-15

Similar Documents

Publication Publication Date Title
CY1115401T1 (el) Συνθεσεις για χορηγηση απο του στοματος δραστικων ενωσεων που απαιτουν συγκαλυψη της γευσης
CA2495230A1 (en) Protection of fragrance in a wax candle using an antioxidant
YU86001A (sh) Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
BR9908578A (pt) Composição cosmética
WO2007076444A3 (en) Improved oral compositions comprising zinc citrate and/or tocopherol agents
AR051972A1 (es) Composiciones de perfume
NZ301681A (en) composition containing an emulsion comprising fatty acid derivatives and a compound of vegetal origin which can be used to modify the behaviour of cats
CR20110483A (es) Preparacion de pregabalina y compuestos relacionados (divisional de expediente 8765)
ES2164785T3 (es) Composiciones orales que contienen compuestos estannosos estabilizados.
WO2005034908A3 (en) A solid dosage form comprising a fibrate and a statin
BRPI0908472A2 (pt) método para produção de etanol a partir de dois diferentes materiais iniciais
BR0311764A (pt) Composição herbicida
ATE531368T1 (de) Tacrolimus enthaltende zusammensetzungen mit modifizierter freisetzung
DE60323354D1 (de) Zusammensetzungen, die kurz-und langkettige fettsäuren enthalten, sowie verfahren zu ihrer anwendung
TW200531696A (en) Pharmaceutical formulations of bisphosphonates
ATE422350T1 (de) Anisinsäure und glyceride enthaltende zusammensetzungen
EA201000752A1 (ru) Фармацевтическая композиция, содержащая эзетимиб
RU2002126553A (ru) Композиции, содержащие миноксидил
ES2194679T3 (es) Composiciones cosmeticas que contienen creatina, carnitina y/o acido piruvico.
BRPI0515958A (pt) composição agroquìmica contendo éster de ácido fosfórico
CY1106127T1 (el) Φαρμακευτικη συσταση ελεγχομενης αποδεσμευσης που πepιεχει υδροχλωρικη τραμαδολη
WO2000015179A3 (en) Cosmetic composition
BRPI0309651B8 (pt) método para prevenir ou reduzir a resistência a um pesticida de uma peste de substrato, composição de pesticida, uso dos mesmos, e, método para preparar uma composição de pesticida
BR0210098B1 (pt) compostos de fragrÂncia
ES2178188T3 (es) Composiciones antitusigenas que contienen teobromina.